CYP17 gene polymorphisms:: Prevalence and associations with hormone levels and related factors.: A HuGE review

被引:93
作者
Sharp, L [1 ]
Cardy, AH [1 ]
Cotton, SC [1 ]
Little, J [1 ]
机构
[1] Univ Aberdeen, Dept Med & Therapeut, Epidemiol Grp, Aberdeen, Scotland
基金
英国医学研究理事会;
关键词
CYP17; epidemiology; genetics; gonadal steroid hormones; hormones; menarche; polymorphism (genetics); steroid; 17-alpha-hydroxylase;
D O I
10.1093/aje/kwh287
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The cytochrome P-450c17alpha (CYP17 ) gene, located on chromosome 10q24.3, encodes the enzyme cytochrome P-450c17alpha, which functions at key branch points in steroid hormone biosynthesis. Three polymorphisms have been described, but only the single base-pair change in the 5'-untranslated region (5'-UTR) has been investigated to any great extent. In single studies, the variant was associated with reduced messenger RNA level in ovarian cells but not with messenger RNA level in breast tissue. Homozygosity for the 5'-UTR variant is most common in East Asian (32%) and Japanese (22%) populations and is less common among White (mainly European and North American (14%)) and Black (mainly African-American (13%)) populations, but selection biases are likely to have affected these frequency estimates. Genotype appears to influence circulating estrogen levels in premenopausal women, while studies of relations with hormone levels in men have produced inconclusive results. However, relatively few studies have been conducted. Seven of 11 retrospective studies suggested a modest association between genotype and age at menarche. Random error in recall of age at menarche is likely to have attenuated this relation. Associations between genotype and postmenopausal estrogen use and bone mass have been observed in single studies. Further investigation of relations between genotype and hormone levels, exogenous hormone use, and markers of hormonal status may advance understanding of hormonally mediated diseases.
引用
收藏
页码:729 / 740
页数:12
相关论文
共 86 条
[1]  
Ahmad N, 2002, CANCER EPIDEM BIOMAR, V11, P147
[2]  
Allen NE, 2001, CANCER EPIDEM BIOMAR, V10, P185
[3]   CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors [J].
Ambrosone, CB ;
Moysich, KB ;
Furberg, H ;
Freudenheim, JL ;
Bowman, ED ;
Ahmed, S ;
Graham, S ;
Vena, JE ;
Shields, PG .
BREAST CANCER RESEARCH, 2003, 5 (02) :R45-R51
[4]   SOME ENDOCRINE CHARACTERISTICS OF EARLY MENARCHE, A RISK FACTOR FOR BREAST-CANCER, ARE PRESERVED INTO ADULTHOOD [J].
APTER, D ;
REINILA, M ;
VIHKO, R .
INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (05) :783-787
[5]  
Banks E, 2002, IARC Sci Publ, V156, P301
[6]  
Bergman-Jungestrom M, 1999, INT J CANCER, V84, P350, DOI 10.1002/(SICI)1097-0215(19990820)84:4<350::AID-IJC3>3.0.CO
[7]  
2-L
[8]   TISSUE-SPECIFIC, CYCLIC ADENOSINE 3',5'-MONOPHOSPHATE-INDUCED, AND PHORBOL ESTER-REPRESSED TRANSCRIPTION FROM THE HUMAN P450C 17 PROMOTER IN MOUSE CELLS [J].
BRENTANO, ST ;
PICADOLEONARD, J ;
MELLON, SH ;
MOORE, CCD ;
MILLER, WL .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (12) :1972-1979
[9]   POLYCYSTIC OVARIES AND PREMATURE MALE PATTERN BALDNESS ARE ASSOCIATED WITH ONE ALLELE OF THE STEROID-METABOLISM GENE CYP17 [J].
CAREY, AH ;
WATERWORTH, D ;
PATEL, K ;
WHITE, D ;
LITTLE, J ;
NOVELLI, P ;
FRANKS, S ;
WILLIAMSON, R .
HUMAN MOLECULAR GENETICS, 1994, 3 (10) :1873-1876
[10]  
Chang BL, 2001, INT J CANCER, V95, P354, DOI 10.1002/1097-0215(20011120)95:6<354::AID-IJC1062>3.0.CO